...
首页> 外文期刊>Urology >Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
【24h】

Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.

机译:反复注射A型肉毒毒素来治疗因神经原性逼尿肌过度活动引起的尿失禁后的治疗效果持续存在。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To study the effect of repeated botulinum toxin type A injections into the detrusor in patients with neurogenic detrusor overactivity and incontinence to determine the safety of repeated injections, the persistence of the clinical and urodynamic treatment efficacy, and potential changes in bladder compliance. METHODS: Seventeen patients with neurogenic detrusor overactivity who had received three or more botulinum toxin type A injections into the detrusor were studied. The clinical and urodynamic data were analyzed at baseline (before the first injection), after the first injection, and after the last repeated injection. RESULTS: No systemic side effects were observed for the total of 91 injections. The mean number of injections per patient was 5.4 (range 3 to 9). The mean number of incontinence episodes per day decreased from 2.6 at baseline to 0 after the first injection, and remained at 0 after the last injection. The maximal cystometric bladder capacity and reflex volume increased significantly after the first and last injection compared with at baseline. The maximal detrusor pressure decreased significantly after the first and last injection compared with at baseline. No difference in compliance was found from baseline to the first or last injection. CONCLUSIONS: Repeated injections of botulinum toxin A into the detrusor muscle are a safe and valuable treatment option for neurogenic detrusor overactivity. After repeated injections, the effect on the clinical and urodynamic parameters remained constant. Also, repeated injections did not decrease bladder compliance.
机译:目的:研究反复注射A型肉毒杆菌毒素对神经源性逼尿肌过度活动和尿失禁患者逼尿肌的影响,以确定重复注射的安全性,临床和尿动力学治疗效果的持久性以及膀胱顺应性的潜在变化。方法:研究了十七名神经原性逼尿肌过度活动的患者,他们接受了三次或更多的A型肉毒杆菌毒素注射。在基线(第一次注射之前),第一次注射之后和最后一次重复注射之后分析临床和尿动力学数据。结果:总共91次注射未观察到全身性副作用。每位患者的平均注射次数为5.4(范围为3到9)。每天平均失禁发作次数从基线的2.6降低到第一次注射后的0,并在最后一次注射后保持在0。与基线相比,第一次和最后一次注射后,最大膀胱测量膀胱容量和反射体积显着增加。与基线相比,第一次和最后一次注射后,最大逼尿肌压力显着下降。从基线到第一次或最后一次注射,依从性没有差异。结论:反复向逼尿肌注射肉毒杆菌毒素A是治疗神经源性逼尿肌过度活动的安全且有价值的治疗选择。反复注射后,对临床和尿动力学参数的影响保持恒定。同样,重复注射并没有降低膀胱顺应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号